PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$277.62
+15.03 (+5.72%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Price Target
Analyst Price Target
-93.0% upside
Low Target
$15.93
Average Target
$19.45
High Target
$25.00
Current Price
$277.62
Current
$277.62
$277.62
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Scenario Analysis
Bear Case
$15.93
-94.3%
Low target
Base Case
$19.45
-93.0%
Avg target
Bull Case
$25.00
+-91.0%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$392.70
-29.3% from high
52-Week Low
$154.45
+79.7% from low
50-Day SMA
$291.73
-4.8% vs SMA
200-Day SMA
$313.95
-11.6% vs SMA
RSI (14)
57.3
Neutral
Target vs 52W High
$19.45
-95.0% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-3.86
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |